E. Oberjé
University of Amsterdam
10 Papers
37 Citations
E. Oberjé is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Cost effectiveness & Health care. The author has an hindex of 6, co-authored 10 publications. Previous affiliations of E. Oberjé include Zuyd University of Applied Sciences.
Chat about Author
Papers
Looking Beyond Health-Related Quality of Life: Predictors of Subjective Well-Being among People Living with HIV in the Netherlands.
E. Oberjé,Alexandra L. Dima,Astrid G. W. van Hulzen,J.M. Prins,Marijn de Bruin,Marijn de Bruin +5 more
TL;DR: Given that most of HIV-care is directed at improving physical health, from the perspective of promoting SWB HIV care should also be directed at other life domains, andPhysical health, social well-being, and financial well- being to a lesser extent.
29
Antimicrobial Stewardship Initiatives Throughout Europe: Proven Value for Money.
TL;DR: Although the best approach to effectively hinder the spread of antimicrobial resistance remains unclear and may vary significantly among settings, several EU-wide examples demonstrate that cost-effective antimicrobial stewardship is possible and can encourage others to implement (the most cost- effective) elements in their system.
Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: design of a multi-centre randomised controlled trial
E. Oberjé,Marijn de Bruin,Silvia M. A. A. Evers,Wolfgang Viechtbauer,Hans-Erik Nobel,Herman P. Schaalma,Jim McCambridge,Luuk Gras,Eric Tousset,Jan M. Prins +9 more
TL;DR: It is anticipated that, if proven cost-effective, AIMS can contribute to improved evidence-based counselling guidelines for HIV-nurses and other health care professionals and full evaluation of the quality of the study design is described.
Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation.
Ben F. M. Wijnen,E. Oberjé,E. Oberjé,Silvia M. A. A. Evers,Jan M Prins,Hans-Erik Nobel,Cees van Nieuwkoop,Jan Veenstra,Frank J Pijnappel,Frank P. Kroon,Laura van Zonneveld,Astrid G. W. van Hulzen,Marjolein van Broekhuizen,Marijn de Bruin +13 more
TL;DR: This study examines the trial-based cost-effectiveness and cost-utility of the proven-effective Adherence Improving Self-Management Strategy (AIMS), from a societal perspective, with a 15-month time horizon, confirming and complements a model-based economic evaluation with a lifetime horizon showing that AIMS is cost-effective.